top of page
Explore the newest research developments at Biokin AIMS.


Revolutionizing Friedreich Ataxia Assessment: How a Multiview IMU System is Setting a New Standard
Friedreich ataxia (FRDA) is a challenging progressive neurodegenerative disease that significantly impacts an individual's motor...
Jun 234 min read


Revolutionizing Friedreich Ataxia Assessment: How AI is Enhancing the Reliability of Motor Function Measurement
Friedreich Ataxia (FRDA) is a debilitating neurodegenerative disorder that progressively impairs motor function, significantly affecting...
Jun 234 min read


Shining a Light on Friedreich's Ataxia: Predicting Loss of Ambulation with Cutting-Edge Technology
Friedreich's Ataxia (FRDA) is a challenging progressive neurodegenerative condition that typically manifests between the ages of 10 and...
Jun 154 min read


Unlocking Voice Health: How Quantum Machine Learning is Revolutionizing Dysphonia Assessment
Speech is a fundamental part of human communication, but for many, conditions like dysphonia can make it incredibly challenging....
Jun 154 min read


Preliminary Results of Phenotype Characterisation for CerebellarAtaxia using Automated Lower Limb Assessment
Cerebellar Ataxias (CAs) are a group of complex neurological disorders characterized by problems with the cerebellum, the part of the...
Jun 153 min read


Objective and quantified instrumented measurement of ataxia in children with Friedreich ataxia
We're excited to share insights into our latest research, which is set to significantly enhance how we assess Friedreich’s Ataxia (FRDA)...
Jun 153 min read


Meet BioBot: Your AI Companion for Ataxia
BioBot provides empathetic, evidence-based support for individuals, caregivers, and researchers dealing with neurodegenerative ataxia,...
Jun 151 min read
bottom of page